Presence, recent use, and impairment are different questions
THC in blood supports exposure. Depending on the concentration, specimen, timing, and use history, it may also support relatively recent use. Functional impairment is a separate conclusion about driving-related abilities at a particular time.
The distinction matters because THC enters and leaves blood differently from alcohol. Concentrations may fall rapidly after smoking while effects continue, and frequent users may have measurable THC after a period of abstinence. A single number therefore cannot be read as a direct scale of impairment.
Persistent THC in frequent users
Karschner and colleagues monitored 25 frequent, long-term cannabis users on a secure research unit for seven days. Sixteen participants had at least one measurable whole-blood THC result during abstinence, and six still had detectable THC on day seven.
The study does not prove that every chronic user remains impaired whenever residual THC is detected. It shows why a measurable concentration does not always establish very recent use and why use history is part of interpretation.
The concentration and performance problem
Controlled driving studies do not produce a simple rule that a particular whole-blood THC concentration equals a particular degree of impairment. Brooks-Russell and colleagues compared daily and occasional users in a driving simulator after acute cannabis use. The groups had different blood concentrations and showed different patterns across lateral control and speed.
The study is evidence that acute use can affect driving-related performance. It is also evidence that use history, tolerance, compensatory behavior, endpoint selection, and study timing complicate any concentration-only conclusion.
An analysis should identify the specimen matrix and collection delay. Whole blood, plasma, and serum values are not interchangeable. A result collected well after driving may not represent the concentration during driving, and a mathematically precise retrograde extrapolation is generally not available in the way it may be attempted with ethanol.
What field sobriety tests can and cannot show
Field sobriety tests were developed and validated principally in the alcohol context. Research on cannabis shows a more qualified picture.
In a 2012 placebo-controlled study of 20 heavy cannabis users, Bosker and colleagues reported that the standardized field sobriety tests were only mildly sensitive to cannabis-related impairment under the study conditions.
A larger randomized trial by Marcotte and colleagues found that highly trained officers distinguished THC and placebo groups at different rates and that selected test findings were associated with simulator performance. But many placebo participants also failed to complete test components as instructed, and officers frequently attributed poor performance to THC. The balanced interpretation is not that field tests are worthless or conclusive. Performance must be evaluated with test limitations, administration quality, baseline or medical explanations, and the rest of the evidence.
Route, dose, and experience matter
Spindle and colleagues compared smoked and vaporized cannabis in healthy adults who used cannabis infrequently. Their controlled crossover work demonstrates that route and dose affect acute drug exposure and outcomes. It also warns against transferring results from one product, route, dose, and population to a factually different case.
A complete analysis should therefore consider product type, reported or inferred route, time of use, frequency of use, collection delay, other substances, sleep, medical conditions, and the behaviors actually observed.
A practical forensic checklist
- Identify whether the specimen was whole blood, plasma, or serum.
- Confirm the exact collection time and documented driving time.
- Review THC, 11-hydroxy-THC, and THC-COOH results and reporting limits.
- Obtain the analytical method, uncertainty, chain of custody, and quality controls.
- Evaluate cannabis-use history and the possibility of residual concentrations.
- Consider product, route, dose, and time-of-use evidence.
- Review driving pattern, officer observations, and test administration details.
- Account for alcohol, medications, other drugs, sleep, and medical conditions.
- Determine whether each cited study matches the specimen, population, timing, and outcome at issue.
The proper scientific task is not to ignore the THC result. It is to prevent the result from being asked to prove more than the research supports.
References
- Karschner EL, Schwilke EW, Lowe RH, et al. Do delta-9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? Addiction. 2009;104(12):2041-2048. doi:10.1111/j.1360-0443.2009.02705.x.
- Bosker WM, Theunissen EL, Conen S, et al. Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users. Psychopharmacology. 2012;223(4):439-446. doi:10.1007/s00213-012-2732-y.
- Marcotte TD, Umlauf A, Grelotti DJ, et al. Evaluation of field sobriety tests for identifying drivers under the influence of cannabis. JAMA Psychiatry. 2023;80(9):914-923. doi:10.1001/jamapsychiatry.2023.2345.
- Brooks-Russell A, Brown T, Friedman K, et al. Simulated driving performance among daily and occasional cannabis users. Accident Analysis and Prevention. 2021;160:106326. doi:10.1016/j.aap.2021.106326.
- Spindle TR, Cone EJ, Schlienz NJ, et al. Acute effects of smoked and vaporized cannabis in healthy adults who infrequently use cannabis. JAMA Network Open. 2018;1(7):e184841. doi:10.1001/jamanetworkopen.2018.4841.
- Compton R. Marijuana-Impaired Driving: A Report to Congress. National Highway Traffic Safety Administration. DOT HS 812 440. July 2017.
General educational and marketing material only. It is not legal advice, expert opinion, or a statement of scientific fact. Full Content Disclaimer.